Physician profile
Sierra Corbin
NPI 1336724434
$2,167.99
in general payments reported to CMS, 2019-2025
12 companies · $706 in 2025
The $706 reported for 2025 was more than what 84% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $467 · 2023: $610 · 2024: $385 · 2025: $706.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,569 · Education: $132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,568.78 |
| Education | $132.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $776.65 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $668.79 | 2022-2025 | Dupixent |
| Aerin Medical INC. | $190.01 | 2024-2025 | |
| Glaxosmithkline, LLC. | $157.08 | 2022-2025 | Nucala |
| Stryker Corporation | $113.01 | 2023 | Xpress Ent Dilation System |
| Abbvie INC. | $91.13 | 2022 | |
| Sanofi-Aventis U.S. LLC | $45.56 | 2022 | |
| Alk-Abello, INC | $34.01 | 2022 | |
| Amgen INC. | $34.00 | 2025 | |
| Lilly USA, LLC | $22.51 | 2024 | Zepbound, Jardiance |
| Medtronic, INC. | $19.11 | 2023 | Propel |
| Integra Lifesciences Corporation | $16.13 | 2024 | Inspira Air, Acclarent Aera, Trudi Probe |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sierra Corbin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.